Chris Copland

Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

S. Knudsen, Martha Donoghue, G. Vassal, 2022, European journal of cancer.

Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol

A. Gavin, M. King, M. Brundage, 2018, BMJ Open.

Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol

A. Gavin, M. King, M. Brundage, 2016, BMJ Open.

Implementation of mechanism of action biology-driven early drug development for children with cancer.

K. Norga, S. Pfister, P. Kearns, 2016, European journal of cancer.

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.

W. Klapper, K. Norga, B. Burkhardt, 2019, European journal of cancer.

ACCELERATE and EMA Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children Authors

W. Klapper, K. Norga, B. Burkhardt, 2019 .

Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

K. Norga, L. Marshall, P. Blanc, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.